Patents Assigned to Cytomatrix, LLC
-
Publication number: 20080063652Abstract: The invention provides culture systems for the generation, expansion and isolation of regulatory T cells. These culture systems can be used to screen for factors that modulate regulatory T cell development. Regulatory T cells derived from such cultures can be used in various in vitro and in vivo applications, as can culture populations depleted of such cells.Type: ApplicationFiled: March 29, 2005Publication date: March 13, 2008Applicant: Cytomatrix, LLCInventors: Mark J. Pykett, Michael Rosenzweig
-
Publication number: 20080064101Abstract: The invention relates to a method for lymphoid tissue-specific cell production from hematopoietic progenitor cells in unique, three-dimensional culture devices, in the presence of antigen presenting cells and lymphoreticular stromal cells, and in the absence of exogenously added growth factors. The resulting lymphoid tissue-specific cells may be isolated at any sequential stage of differentiation and further expanded. The lymphoid tissue-specific cells also may be genetically altered at any stage of the process.Type: ApplicationFiled: January 31, 2007Publication date: March 13, 2008Applicants: Cytomatrix, LLC, The General Hospital CorporationInventors: Mark Pykett, Michael Rosenzweig, David Scadden, Mark Poznansky
-
Publication number: 20070148769Abstract: The invention pertains to methods and devices for the long term, in vitroculture of hematopoietic progenitor cells in the absence of exogenously added hematopoietic growth factors, improved methods for the introduction of foreign genetic material into cells of hematopoietic origin, and to apparatus for performing these methods. The hematopoietic progenitor cells are cultured on a three-dimensional porous biomaterial. The three-dimensional porous biomaterial enhances hematopoietic progenitor cell survival and leads to an expansion of progenitor cell numbers and/or functionality, while maintaining progenitor cell pluripotency in the absence of exogenous growth factors. In addition, the three-dimensional porous biomaterial supports high level transduction on cells cultured upon such environment.Type: ApplicationFiled: June 26, 2006Publication date: June 28, 2007Applicant: Cytomatrix, LLCInventors: Mark Pykett, Michael Rosenzweig, Richard Kaplan
-
Publication number: 20070127276Abstract: A power supply capable of making soft start efficiently. A power supply (10) is such that the time lag from the soft start trigger representing the start of soft start control to the actual soft start can be decreased by offsetting the potential of a soft start signal from the ground potential. The offset is slightly lower than the minimum potential of a triangular signal. The highest potential level of the soft start signal is preferably lower than the power supply potential.Type: ApplicationFiled: March 30, 2005Publication date: June 7, 2007Applicant: CYTOMATRIX LLCInventors: Yusaku Yoshimatsu, Takumi Katoh, Yuji Nozasa
-
Patent number: 7192769Abstract: The invention relates to a method for lymphoid tissue-specific cell production from hematopoietic progenitor cells in unique, three-dimensional culture devices, in the presence of antigen presenting cells and lymphoreticular stromal cells, and in the absence of exogenously added growth factors. The resulting lymphoid tissue-specific cells may be isolated at any sequential stage of differentiation and further expanded. The lymphoid tissue-specific cells also may be genetically altered at any stage of the process.Type: GrantFiled: May 31, 2002Date of Patent: March 20, 2007Assignee: Cytomatrix, LLCInventors: Mark J. Pykett, Michael Rosenzweig, David T. Scadden, Mark C. Poznansky
-
Publication number: 20060194310Abstract: The present invention relates to culturing devices that are compact, utilize small amounts of cell culture media to establish and maintain cell cultures, and produce a large number of cells in a short period of time when compared to other cell culturing devices and techniques. Such devices are useful in the culture of all cell types, but are particularly useful in the culture of cells that are known in the art to be difficult to culture, including cells that lose one or more of their particular attributes/characteristics (e.g., pluripotentiality), or cells that are difficult to establish cultures of (e.g., primary cells), during culturing in traditional cell culture devices.Type: ApplicationFiled: January 30, 2006Publication date: August 31, 2006Applicant: Cytomatrix, LLCInventors: Todd Upton, John Flickinger
-
Patent number: 7067316Abstract: The invention pertains to methods and devices for the long term, in vitroculture of hematopoietic progenitor cells in the absence of exogenously added hematopoietic growth factors, improved methods for the introduction of foreign genetic material into cells of hematopoietic origin, and to apparatus for performing these methods. The hematopoietic progenitor cells are cultured on a three-dimensional porous biomaterial. The three-dimensional porous biomaterial enhances hematopoietic progenitor cell survival and leads to an expansion of progenitor cell numbers and/or functionality, while maintaining progenitor cell pluripotency in the absence of exogenous growth factors. In addition, the three-dimensional porous biomaterial supports high level transduction on cells cultured upon such environment.Type: GrantFiled: November 10, 2003Date of Patent: June 27, 2006Assignee: Cytomatrix, LLCInventors: Mark J. Pykett, Michael Rosenzweig, Richard B. Kaplan
-
Patent number: 6991933Abstract: The present invention relates to culturing devices that are compact, utilize small amounts of cell culture media to establish and maintain cell cultures, and produce a large number of cells in a short period of time when compared to other cell culturing devices and techniques. Such devices are useful in the culture of all cell types, but are particularly useful in the culture of cells that are known in the art to be difficult to culture, including cells that lose one or more of their particular attributes/characteristics (e.g., pluripotentiality), or cells that are difficult to establish cultures of (e.g., primary cells), during culture in traditional cell culture devices.Type: GrantFiled: September 22, 2000Date of Patent: January 31, 2006Assignee: Cytomatrix, LLCInventors: Todd M. Upton, John T. Flickinger
-
Publication number: 20050079609Abstract: The invention pertains to methods and devices for the long term, in vitroculture of hematopoietic progenitor cells in the absence of exogenously added hematopoietic growth factors, improved methods for the introduction of foreign genetic material into cells of hematopoietic origin, and to apparatus for performing these methods. The hematopoietic progenitor cells are cultured on a three-dimensional porous biomaterial. The three-dimensional porous biomaterial enhances hematopoietic progenitor cell survival and leads to an expansion of progenitor cell numbers and/or functionality, while maintaining progenitor cell pluripotency in the absence of exogenous growth factors. In addition, the three-dimensional porous biomaterial supports high level transduction on cells cultured upon such environment.Type: ApplicationFiled: November 10, 2003Publication date: April 14, 2005Applicant: Cytomatrix, LLCInventors: Mark Pykett, Michael Rosenzweig, Richard Kaplan
-
Patent number: 6645489Abstract: The invention pertains to methods and devices for the long term, in vitroculture of hematopoietic progenitor cells in the absence of exogenously added hematopoietic growth factors, improved methods for the introduction of foreign genetic material into cells of hematopoietic origin, and to apparatus for performing these methods. The hematopoietic progenitor cells are cultured on a three-dimensional porous biomaterial. The three-dimensional porous biomaterial enhances hematopoietic progenitor cell survival and leads to an expansion of progenitor cell numbers and/or functionality, while maintaining progenitor cell pluripotency in the absence of exogenous growth factors. In addition, the three-dimensional porous biomaterial supports high level transduction on cells cultured upon such environment.Type: GrantFiled: May 10, 2002Date of Patent: November 11, 2003Assignee: Cytomatrix, LLCInventors: Mark J. Pykett, Michael Rosenzweig, Richard B. Kaplan
-
Patent number: 6440734Abstract: The invention pertains to methods and devices for the long term, in vitro culture of hematopoietic progenitor cells in the absence of exogenously added hematopoietic growth factors, improved methods for the introduction of foreign genetic material into cells of hematopoietic origin, and to apparatus for performing these methods. The hematopoietic progenitor cells are cultured on a three-dimensional porous biomaterial. The three-dimensional porous biomaterial enhances hematopoietic progenitor cell survival and leads to an expansion of progenitor cell numbers and/or functionality, while maintaining progenitor cell pluripotency in the absence of exogenous growth factors. In addition, the three-dimensional porous biomaterial supports high level transduction on cells cultured upon such environment.Type: GrantFiled: June 7, 2000Date of Patent: August 27, 2002Assignee: Cytomatrix, LLCInventors: Mark J. Pykett, Michael Rosenzweig, Richard B. Kaplan